(Q28375660)

2

0 references

N Partovi

3

0 references

C H Scudamore

4

0 references

S W Chung

5

0 references

L Frighetto

6

0 references

H J Eggen

7

0 references

U P Steinbrecher

Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization

8

0 references

language of work or name

English

0 references

publication date

November 1999

0 references

published in

Liver Transplantation

0 references

volume

5

0 references

issue

6

0 references

page(s)

520-5

0 references

cites work

1 reference

https://api.crossref.org/works/10.1002%2FLT.500050602

Absence of initial viral replication and long-term high dose immunoglobulin administration improve results of hepatitis B virus recurrence prophylaxis after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500050602

Hepatitis B infection and liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500050602

Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500050602

Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500050602

Incidence and clinical consequences of surface and polymerase gene mutations in liver transplant recipients on hepatitis B immunoglobulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500050602

Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500050602

Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500050602

Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500050602

Postliver transplant allograft reinfection with a lamivudine-resistant strain of hepatitis B virus: long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500050602

Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500050602

Intravenous or intramuscular anti-HBs immunoglobulin for the prevention of hepatitis B reinfection after orthotopic liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500050602

Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLT.500050602